SouthState’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$490 – 1386
2026
Q2
$490 Buy
+2
New +$434 ﹤0.01% 1240

Other funds holding AXSM

SouthState's AXSM Position: Q3 2026 in Review

SouthState sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 2 shares — an estimated $490 sold.

SouthState first reported a position in AXSM in Q2 2026 and held it in 1 quarter. The position peaked at $490 in Q2 2026. 348 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • SouthState reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
  • SouthState sold 2 Axsome Therapeutics shares in Q3 2026, an estimated $490.
  • SouthState first reported a position in Axsome Therapeutics in Q2 2026 and held it in 1 quarter.
  • SouthState's Axsome Therapeutics position peaked at $490 in Q2 2026.
  • 348 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.